|
Metabolic
Profiles
Comprehensive
Cardiovascular Profile 2.0
This profile provides state of the art assessment of cardiovascular
risk and response to treatment. Utilizing VAP lipid fractionazation
technology, physicians can increase their detection of cardiovascular
disease risk from 55% with standard lipid profiles to greater than
85% with this test. Inclusion of lipid-independent risk factors
such as homocysteine, hs C-reactive protein, and fibrinogen provides
effective means to assess methylation impairments, inflammation,
and hemostatic factors that relate strongly to cardiovascular disease.
|
Sample
Report
Support
Guide
|